Literature DB >> 8752156

2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican.

Z Isogai1, T Shinomura, N Yamakawa, J Takeuchi, T Tsuji, D Heinegård, K Kimata.   

Abstract

2B1 is a monoclonal antibody against a large proteoglycan isolated from human yolk sac tumor (M. Sobue et al., Histochem. J., 21: 455-460, 1989). The antigen is expressed in a variety of embryonal tissues as well as most if not all malignant tumor tissues. However, the expression in normal adult tissues is limited to some tissues, such as the smooth muscle layers of the aorta. We characterized the 2B1 antigen isolated from the conditioned medium of human malignant fibrous histiocytoma and found that immunological and biochemical properties are identical to those of a large chondroitin sulfate proteoglycan, PG-M/versican. Partial amino acid sequences of peptides obtained from the core protein by V8 protease digestion and subsequent SDS-PAGE were detected in the reported amino acid sequence of human PG-M/versican with a complete identity. Furthermore, 2B1 was distinctly reactive to the expressed protein by transfection of the cDNA for the shortest form into mouse cells. The results indicate that the antigen is the PG-M core protein, and the epitope may be in one of the globular domains. It is thus likely that PG-M/versican is one of the extracellular matrix components characteristic of human malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752156

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Age-related differences in human skin proteoglycans.

Authors:  David A Carrino; Anthony Calabro; Aniq B Darr; Maria T Dours-Zimmermann; John D Sandy; Dieter R Zimmermann; J Michael Sorrell; Vincent C Hascall; Arnold I Caplan
Journal:  Glycobiology       Date:  2010-10-14       Impact factor: 4.313

2.  V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling.

Authors:  Daniel Hernández; Laia Miquel-Serra; María-José Docampo; Anna Marco-Ramell; Jennifer Cabrera; Angels Fabra; Anna Bassols
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

3.  Developing vasculature and stroma in engineered human myocardium.

Authors:  Kareen L Kreutziger; Veronica Muskheli; Pamela Johnson; Kathleen Braun; Thomas N Wight; Charles E Murry
Journal:  Tissue Eng Part A       Date:  2011-02-02       Impact factor: 3.845

4.  Adsorption of follicular dendritic cell-secreted protein (FDC-SP) onto mineral deposits. Application of a new stable gene expression system.

Authors:  Tamayuki Shinomura; Sayaka Nakamura; Kazuo Ito; Shin-ichi Shirasawa; Magnus Höök; James H Kimura
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

5.  High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.

Authors:  Matti Pukkila; Ari Kosunen; Kirsi Ropponen; Jukka Virtaniemi; Jari Kellokoski; Eero Kumpulainen; Risto Pirinen; Juhani Nuutinen; Risto Johansson; Veli-Matti Kosma
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

6.  A monoclonal antibody which recognizes a glycosaminoglycan epitope in both dermatan sulfate and chondroitin sulfate proteoglycans of human skin.

Authors:  J M Sorrell; D A Carrino; M A Baber; D Asselineau; A I Caplan
Journal:  Histochem J       Date:  1999-08

7.  The accumulation of versican in the nodules of benign prostatic hyperplasia.

Authors:  Lawrence D True; Sarah Hawley; Thomas H Norwood; Kathleen R Braun; Stephen P Evanko; Christina K Chan; Richard C LeBaron; Thomas N Wight
Journal:  Prostate       Date:  2009-02-01       Impact factor: 4.104

8.  Homotypic versican G1 domain interactions enhance hyaluronan incorporation into fibrillin microfibrils.

Authors:  Yusuke Murasawa; Ken Watanabe; Masahiko Yoneda; Masahiro Zako; Koji Kimata; Lynn Y Sakai; Zenzo Isogai
Journal:  J Biol Chem       Date:  2013-08-20       Impact factor: 5.157

9.  Increased versican content is associated with tendinosis pathology in the patellar tendon of athletes with jumper's knee.

Authors:  A Scott; Ø Lian; C R Roberts; J L Cook; C J Handley; R Bahr; T Samiric; M Z Ilic; J Parkinson; D A Hart; V Duronio; K M Khan
Journal:  Scand J Med Sci Sports       Date:  2007-12-07       Impact factor: 4.221

10.  Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study.

Authors:  M J Pukkila; A S T Kosunen; J A Virtaniemi; E J Kumpulainen; R T Johansson; J K Kellokoski; J Nuutinen; V-M Kosma
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.